Ipamorelin

Targeted Growth Hormone Signaling • Sleep-Driven Recovery • Metabolic Support

Ipamorelin is a prescription-only growth hormone secretagogue designed to stimulate the body’s natural growth hormone (GH) release through selective ghrelin receptor activation. Unlike broader GH-axis compounds, Ipamorelin provides focused, pulsatile GH stimulation while preserving physiologic rhythm and normal endocrine feedback mechanisms.

Within clinician-directed optimization frameworks, Ipamorelin is valued for its favorable tolerability profile and precision signaling. Its targeted mechanism supports recovery capacity, sleep-associated repair, lean tissue preservation, and metabolic efficiency—without directly administering exogenous growth hormone or significantly impacting other pituitary hormones.

Because of its selective activity and lower systemic burden, Ipamorelin is commonly incorporated into foundational or long-duration protocols, particularly when sleep quality, recovery support, and sustainable endocrine balance are priorities.

ASPN Insight

At ASPN, Ipamorelin is positioned as a precision growth hormone signaling therapy, often utilized when gentle, well-tolerated GH support is desired. It is frequently selected for individuals prioritizing sleep quality, recovery efficiency, and long-term metabolic resilience under clinician supervision.

Who This May Be Considered For

Ipamorelin may be evaluated by an ASPN clinician for individuals seeking:

• Support for natural growth hormone pulsatility

• Improved sleep-associated recovery signaling

• A lower-burden GH secretagogue option

• Long-term endocrine and metabolic support

Final determination is made by a licensed medical provider following individualized assessment.

Prescription & Payment Notice

Ipamorelin is a prescription-only peptide therapy provided exclusively within ASPN’s clinician-guided programs due to its role in endocrine signaling and recovery support.

Ipamorelin is prescribed by a licensed medical provider and dispensed through a U.S.-licensed compounding pharmacy in accordance with applicable state and federal regulations. ASPN does not manufacture, compound, or dispense prescription medications.

To ensure appropriate medical evaluation, protocol alignment, and individualized clinical oversight, orders for prescription products are subject to a temporary payment authorization hold at checkout. Charges are finalized only after prescription approval and clinical clearance are completed.

This process supports safety, regulatory compliance, and personalized care as part of ASPN’s concierge medical model.

Prescription-only product. Intended to support normal hormonal, metabolic, and physiological function under the supervision of a qualified healthcare professional. Not intended to diagnose, treat, cure, or prevent any disease.